BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
latest_posts
- 1
Highlight Correlation of Microsoft Surface Book and Surface Genius Workstations for Determination - 2Trump administration plan to reduce access to some student loans angers nurses, health care groups
- 3Monetary Versatility: Get ready for Life's Unforeseen Difficulties
- 4Step by step instructions to Pick the Right Sunlight powered charger Type for Your Home
- 5Figure out How to Function Successfully with Your Auto Collision Legal advisor for the Best Result
- Which Exhibition hall Do You Suggest? Vote
- Two Indonesian UN peacekeepers killed in explosion in Lebanon
- Kids get diseases like lupus, too. As researchers hunt better treatments, this camp brings joy
- Instructions to Keep an Inspirational perspective After Cellular breakdown in the lungs Treatment
- Oil, energy and food: Which countries in Europe are most exposed to higher food prices?
- Allow Innovative Progressions To have a Tremendous Effect
- Ariana Grande to host 'Saturday Night Live' Christmas show with Cher as musical guest, returning after nearly 40 years
- Flu season is just beginning, but doctors are already on high alert
- 2024 Moving Styles for Kitchen Redesigns
